CORRECTED-UPDATE 2-Novartis sickle-cell drug gets U.S. FDA approval
November 16, 2019 at 12:02 PM EST
Novartis AG on Friday won U.S. approval for its experimental sickle cell disease drug, Adakveo, making it the first of several proposed new therapies designed to offer lasting relief for patients with the debilitating blood disease to get U.S. regulatory clearance.